White Bay PT »

Iovance Biotherapeutics shares owned by White Bay PT

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by White Bay PT from 13F filings

Historical chart of White Bay PT investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by White Bay PT consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by White Bay PT

Quarter filed Position value Share count Share price at filing
2023-09-30 $35k 7.8k 4.50

More positions owned by White Bay PT

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Seagen
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Horizon Therapeutics Pub L SHS
Ishares Tr S&p 100 Etf Call Option (OEF)
Activision Blizzard
Vmware Cl A Com
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Altria (MO)
Johnson & Johnson Call Option (JNJ)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Intercontinental Exchange Put Option (ICE)

View all positions for White Bay PT

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Susquehanna International
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics